REDWOOD CITY, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results